Kliniken & Institute ... Kliniken Zentrum für Innere... Innere Medizin V:... Behandlungsspektrum ... Onkologie Sarkome Publikationen

Ausgewählte Publikationen

1. Impact of dynamic 18F-FDG PET on the early prediction of therapy outcome in patients with high-risk soft-tissue sarcomas after neoadjuvant chemotherapy: a feasibility study.
Dimitrakopoulou-Strauss A, Strauss LG, Egerer G, Vasamiliette J, Mechtersheimer G, Schmitt T, Lehner B, Haberkorn U, Stroebel P, Kasper B.
J Nucl Med. 2010; 51, 551-558.

2. Prediction of chemotherapy outcome in patients with metastatic soft tissue sarcomas based on dynamic FDG PET (dPET) and a multiparameter analysis.
Dimitrakopoulou-Strauss A, Strauss LG, Egerer G, Vasamiliette J, Schmitt T, Haberkorn U, Kasper B.
Eur J Nucl Med Mol Imaging. 2010; Mar 25. [Epub ahead of print]

3. Genomic profiling reveals subsets of dedifferentiated liposarcoma to follow separate molecular pathways.
Rieker RJ, Weitz J, Lehner B, Egerer G, Mueller A, Kasper B, Schirmacher P, Joos S, Mechtersheimer G.
Virchows Arch. 2010; 456, 277-285.


4. Consolidation with high-dose chemotherapy and stem cell support for responding patients with metastatic soft tissue sarcomas: prospective, single-institutional phase II study.
Kasper B, Scharrenbroich I, Schmitt T, Wuchter P, Dietrich S, Ho AD, Egerer G.
Bone Marrow Transplant. 2009 Nov 23. [Epub ahead of print]

5. The use of positron emission tomography in soft tissue sarcoma patients under therapy with trabectedin.
Kasper B, Schmitt T, Wuchter P, Dimitrakopoulou-Strauss A, Ho AD, Egerer G.
Mar Drugs. 2009; 7, 331-340.

6. Positron emission tomography as a tool for early prediction of therapy outcome in soft tissue sarcoma.
Kasper B, Schmitt T, Wuchter P, Ho AD, Egerer G.
Dtsch Med Wochenschr. 2009; 134, 1922-1926.

7. New medical treatment options and strategies to assess clinical outcome in soft-tissue sarcoma.
Schmitt T, Kasper B.
Expert Rev Anticancer Ther. 2009, 9, 1159-1167.

8. Early prediction of therapy outcome in patients with high-risk soft tissue sarcoma using positron emission tomography.
Kasper B, Dietrich S, Dimitrakopoulou-Strauss A, Strauss LG, Haberkorn U, Ho AD, Egerer G.
Onkologie. 2008, 31, 107-112

9. Large institutional experience with dose-intensive chemotherapy and stem cell support in the management of sarcoma patients.
Kasper B, Dietrich S, Mechtersheimer G, Ho AD, Egerer G.
Oncology. 2007, 73, 58-64.

10. Dose-intensive chemotherapy with stem cell support as a treatment strategy for bone and soft-tissue sarcomas.
Kasper B, Ho AD, Egerer G.
Curr Stem Cell Res Ther. 2006; 1, 29-35.